Amryt Pharma AMYT Stock
Amryt Pharma Price Chart
Amryt Pharma AMYT Financial and Trading Overview
| Amryt Pharma stock price | 14.7 USD |
| Previous Close | 14.7 USD |
| Open | 14.71 USD |
| Bid | 14.7 USD x 3000 |
| Ask | 14.79 USD x 4000 |
| Day's Range | 14.63 - 14.76 USD |
| 52 Week Range | 6.41 - 14.77 USD |
| Volume | 2.39M USD |
| Avg. Volume | 358.65K USD |
| Market Cap | 942.77M USD |
| Beta (5Y Monthly) | 0.764971 |
| PE Ratio (TTM) | 39.72973 |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 18.67 USD |
AMYT Valuation Measures
| Enterprise Value | 1.07B USD |
| Trailing P/E | 39.72973 |
| Forward P/E | -490 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.8698156 |
| Price/Book (mrq) | 2.8999803 |
| Enterprise Value/Revenue | 4.392 |
| Enterprise Value/EBITDA | -14.492 |
Trading Information
Amryt Pharma Stock Price History
| Beta (5Y Monthly) | 0.764971 |
| 52-Week Change | 80.36% |
| S&P500 52-Week Change | 15.27% |
| 52 Week High | 14.77 USD |
| 52 Week Low | 6.41 USD |
| 50-Day Moving Average | 14.62 USD |
| 200-Day Moving Average | 9.99 USD |
AMYT Share Statistics
| Avg. Volume (3 month) | 358.65K USD |
| Avg. Daily Volume (10-Days) | 447.61K USD |
| Shares Outstanding | 64.13M |
| Float | 37.39M |
| Short Ratio | 0.58 |
| % Held by Insiders | 0.077% |
| % Held by Institutions | 77.30% |
| Shares Short | 229.45K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.36% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -0.32% |
| Operating Margin (ttm) | -16.69% |
| Gross Margin | 54.31% |
| EBITDA Margin | -30.30% |
Management Effectiveness
| Return on Assets (ttm) | -3.19% |
| Return on Equity (ttm) | -0.25% |
Income Statement
| Revenue (ttm) | 243.62M USD |
| Revenue Per Share (ttm) | 3.8 USD |
| Quarterly Revenue Growth (yoy) | 8.20% |
| Gross Profit (ttm) | 120.84M USD |
| EBITDA | -73828000 USD |
| Net Income Avi to Common (ttm) | -790000 USD |
| Diluted EPS (ttm) | 0.37 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 83.25M USD |
| Total Cash Per Share (mrq) | 1.3 USD |
| Total Debt (mrq) | 212.79M USD |
| Total Debt/Equity (mrq) | 65.62 USD |
| Current Ratio (mrq) | 1.568 |
| Book Value Per Share (mrq) | 5.069 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 108.27M USD |
| Levered Free Cash Flow (ttm) | 31.64M USD |
Profile of Amryt Pharma
| Country | United States |
| State | N/A |
| City | Dublin |
| Address | 45 Mespil Road |
| ZIP | 4 |
| Phone | 353 1 518 0200 |
| Website | https://www.amrytpharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 289 |
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.
Q&A For Amryt Pharma Stock
What is a current AMYT stock price?
Amryt Pharma AMYT stock price today per share is 14.7 USD.
How to purchase Amryt Pharma stock?
You can buy AMYT shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Amryt Pharma?
The stock symbol or ticker of Amryt Pharma is AMYT.
Which industry does the Amryt Pharma company belong to?
The Amryt Pharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Amryt Pharma have in circulation?
The max supply of Amryt Pharma shares is 0.
What is Amryt Pharma Price to Earnings Ratio (PE Ratio)?
Amryt Pharma PE Ratio is now.
What was Amryt Pharma earnings per share over the trailing 12 months (TTM)?
Amryt Pharma EPS is 0 USD over the trailing 12 months.
Which sector does the Amryt Pharma company belong to?
The Amryt Pharma sector is Healthcare.
Amryt Pharma AMYT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
- {{ link.label }} {{link}}